Researchers in this study wanted to understand how a gene called KIF14 contributes to breast cancer development and progression. KIF14 is involved in cell division and growth, processes that are tightly controlled in normal cells but often become dysregulated in cancer. The researchers aimed to determine whether increased KIF14 activity plays a role in tumor growth and whether it could be used to predict patient outcomes.
To investigate this, the researchers analyzed breast cancer tissue samples and conducted laboratory experiments using breast cancer cells. They measured levels of KIF14 and examined how changes in its expression affected cell behavior.
They found that KIF14 levels were higher in breast cancer tissue compared to normal tissue. Increased KIF14 activity was associated with faster cell growth and increased tumor progression. In experimental models, reducing KIF14 levels slowed cancer cell growth, suggesting that the gene plays an active role in driving cancer.
Additionally, higher KIF14 expression was linked to poorer patient outcomes, indicating that it may serve as a useful biomarker for predicting disease progression.
